Evofem Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update PRNewswire
SAN DIEGO, May 7, 2019 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) (“Evofem” or the “Company”), a clinical stage biopharmaceutical …